|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Liver transplantation for hepatic tumors:a systematic review显示文摘Improvements in the medical and pharmacological management of liver transplantation(LT)recipients have led to a better long-term outcome and extension of the indications for this procedure.Liver tumors are relevant to LT;however,the use of LT to treat malignancies remains a debated issue because the high risk of recurrence.In this review we considered LT for hepatocellular carcinoma(HCC),cholangiocarcinoma(CCA),liver metastases(LM)and other rare tumors.We reviewed the literature,focusing on the past 10 years.The highly selected Milan criteria of LT for HCC(single nodule<5 cm or up to 3 nodules<3cm)have been recently extended by a group from the University of S.Francisco(1 lesion<6.5 cm or up to3 lesions<4.5 cm)with satisfying results in terms of recurrence-free survival and the'up-to-seven criteria'.Moreover,using these criteria,other transplant groups have recently developed downstaging protocols,including surgical or loco-regional treatments of HCC,which have increased the post-operative survival of recipients.CCA may be treated by LT in patients who cannot undergo liver resection because of underlying liver disease or for anatomical technical challenges.A well-defined protocol of chemoirradiation and staging laparotomy before LT has been developed by the Mayo Clinic,which has resulted in long term diseasefree survival comparable to other indications.LT for LM has also been investigated by multicenter studies.It offers a real benefit for metastases from neuroendocrine tumors that are well differentiated and when a major extrahepatic resection is not required.If LT is an option in these selected cases,liver metastases from colorectal cancer is still a borderline indication because data concerning the disease-free survival are still lacking.Hepatoblastoma and hemangioendothelioma represent rare primary tumors for which LT is often the only possible and effective cure because of the frequent multifocal,intrahepatic nature of the disease.LT is a very promising procedure for both primary and secondary liver malignancies;however,it needs an accurate evaluation of the costs and benefits for each indication to balance the chances of cure with actual organ availability. | Matteo Ravaioli Giorgio Ercolani Flavia Neri Matteo Cescon Giacomo Stacchini Massimo Del Gaudio Alessandro Cucchetti Antonio Daniele Pinna | 2014 | World Journal of Gastroenterology2014，20，18： | 8 |
| 2 | Expression of type HI re-ceptor tyrosine kinase FLT3 and KIT and response to their ligandsby acute myeloid leukemia blasts 显示文摘 | Stacchini A Fubini L Severino A | 1996 | Leukemia1996，10，10： | 1 |
| 3 | Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS dissemination 显示文摘 | Benevolo G Stacchini A Spina M | 2012 | Blood2012，120，16： | 1 |
| 4 | Flow cytometry in the bone marrow staging of mature B-cell neoplasms 显示文摘 | Stacchini A Demurtas A Godio L | 2003 | Cytometry2003，54，1： | 1 |
| 5 | Final results of amulticenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS dissemination显示文摘 | Benevolo G Stacchini A Spina M | 2012 | Blood2012，120，16： | 1 |
| 6 | Evaluation of rapid methods for the determination of okadaic acid in mussels显示文摘 | Croci L Stacchini A Cozzi L | 2001 | J Appl Microbiol2001，90，1： | 1 |
| 7 | Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS dissemination 显示文摘 | Benevolo G Stacchini A Spina M | 2012 | Blood2012，120，32： | 1 |
| 8 | Treatment of multiple network parameter errors through a genetic-based algorithms显示文摘 | STACCHINI DE SOUZA J C DO COUTTO FILHO M B | 2009 | Electric Power Systems Research2009，11，79： | 1 |
| 9 | prognostic relevance of cytometric quantitative assessment in patients with myelodysplastic syndromes显示文摘 | Falco P Levis A Stacchini A | | 0，，： | 1 |
| 10 | Macrolide antibiotics as anti- inflammatory agents:roxithromycin in an unexpecred role显示文摘 | Agen C Danesi R Blandizzi C Costa M Stacchini B Favini P | 1993 | Agents Actions1993，38，： | 1 |
| 11 | Off-line validation of power network branch parameters 显示文摘 | M B Do Coutto J C Stacchini de Souza | 2008 | IET Generation Transmission & Distribution2008，2，6： | 1 |
| 12 | Real-time forecasting regional tourism with business sentiment surveys显示文摘 | Guizzardi A Stacchini A | 2015 | Tourism management2015，47，： | 1 |
| 13 | , Human exposure to lead, cadmium and mercury through fish and seafood product consumption in Italy: a pilot evaluation 显示文摘 | PASTORELLI A A BALDINI M STACCHINI P | 2012 | Food Addtives and Contaminants part A - Chemistry Analysis Control Exposure & Risk Assessment2012，29，12： | 1 |
| 14 | Prognostic relevance of cytometric quantitative assessment, in patients with myelodys- plaetic syndromes显示文摘 | Falco P Levis A Stacchini AA | 2011 | Eur J Haemetol2011，87，5： | 1 |
| 15 | Final results of a multicenter trial addressing role of CSF cytometric analysis in NHL patients at high risk for CNS dissemination显示文摘 | Benevolo G Stacchini A Spina M | 2012 | Blood2012，120，： | 1 |
| 16 | Human exposure to lead, cadmium and mercury through fish and seafood product consumption in Italy: a pilot evaluation 显示文摘 | PASTORELLI A A BALDINI M STACCHINI P | 2012 | Food Additives and Contaminants Part A - Chemistry Analysis Control Exposure & Risk Assessment2012，29，12： | 1 |
| 17 | Human exposure to lead, cadmium and mercury through fish and seafood product consumption in Italy: a pilot evaluation 显示文摘 | PASTORELLI A A BALDINI M STACCHINI P | 2012 | Food Addtives and Contaminants part A - Chemistry Analysis Control Exposure & Risk Assessment2012，29，12： | 1 |
| 18 | Prognostic relevance of cytometric quantitative assessment in patients with myelodysplastic syndromes显示文摘 | Falco P Levis A Stacchini AA | 2011 | Eor J Haematol2011，87，5： | 1 |
| 19 | Prognostic relevance of cytometric quantitative assessment in patients with myelodysplastic syndromes显示文摘 | Falco P Levis A Stacchini A | 2011 | Eur J Haematol2011，87，5： | 1 |
| 20 | Prognostic relevance of cytometric quantitative assessment in patients with myelodysplastic syndromes显示文摘 | FALCO P LEVIS A STACCHINI A A | 2011 | Eur J bIaematol2011，87，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员